Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
Want to see BNR full AI Analyst Report?
Total Valuation
Burning Rock Biotech has a market cap or net worth of $175.65M. The enterprise value is -$320.24M.
Market Cap$175.65M
Enterprise Value-$320.24M
Share Statistics
Burning Rock Biotech has 8,813,858 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,813,858
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Burning Rock Biotech’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -9.28%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-9.28%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee800.55K
Profits Per Employee-82.12K
Employee Count674
Asset Turnover0.66
Inventory Turnover2.40
Valuation Ratios
The current PE Ratio of Burning Rock Biotech is ―. Burning Rock Biotech’s PEG ratio is -0.06.
PE Ratio―
PS Ratio0.28
PB Ratio0.28
Price to Fair Value0.28
Price to FCF-4.51
Price to Operating Cash Flow-4.09
PEG Ratio-0.06
Income Statement
In the last 12 months, Burning Rock Biotech had revenue of 539.57M and earned -55.35M in profits. Earnings per share was -49.60.
Revenue539.57M
Gross Profit402.91M
Operating Income-54.84M
Pretax Income-53.79M
Net Income-55.35M
EBITDA-32.00M
Earnings Per Share (EPS)-49.60
Cash Flow
In the last 12 months, operating cash flow was -28.44M and capital expenditures -5.25M, giving a free cash flow of -33.69M billion.
Operating Cash Flow-28.44M
Free Cash Flow-33.69M
Free Cash Flow per Share-3.82
Dividends & Yields
Burning Rock Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.94
52-Week Price Change405.26%
50-Day Moving Average17.95
200-Day Moving Average17.50
Relative Strength Index (RSI)41.86
Average Volume (3m)22.64K
Important Dates
Burning Rock Biotech upcoming earnings date is Jun 2, 2026, Before Open (Confirmed).
Last Earnings DateMar 12, 2026
Next Earnings DateJun 2, 2026
Ex-Dividend Date―
Financial Position
Burning Rock Biotech as a current ratio of 2.99, with Debt / Equity ratio of 8.06%
Current Ratio2.99
Quick Ratio2.76
Debt to Market Cap0.01
Net Debt to EBITDA13.70
Interest Coverage Ratio-1.83K
Taxes
In the past 12 months, Burning Rock Biotech has paid 1.56M in taxes.
Income Tax1.56M
Effective Tax Rate-0.03
Enterprise Valuation
Burning Rock Biotech EV to EBITDA ratio is 8.95, with an EV/FCF ratio of 8.50.
EV to Sales-0.53
EV to EBITDA8.95
EV to Free Cash Flow8.50
EV to Operating Cash Flow10.07
Balance Sheet
Burning Rock Biotech has $481.39M in cash and marketable securities with $43.15M in debt, giving a net cash position of $438.25M billion.
Cash & Marketable Securities$481.39M
Total Debt$43.15M
Net Cash$438.25M
Net Cash Per Share$49.72
Tangible Book Value Per Share$496.35
Margins
Gross margin is 74.67%, with operating margin of -10.16%, and net profit margin of -10.26%.
Gross Margin74.67%
Operating Margin-10.16%
Pretax Margin-9.97%
Net Profit Margin-10.26%
EBITDA Margin-5.93%
EBIT Margin-9.96%
Analyst Forecast
The average price target for Burning Rock Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.69%
EPS Growth Forecast84.60%